BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 55 filers reported holding BIOLIFE SOLUTIONS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $57 | 0.0% | 2,575 | 0.0% | 0.00% | – |
Q2 2023 | $57 | +1.8% | 2,575 | 0.0% | 0.00% | – |
Q1 2023 | $56 | -5.1% | 2,575 | 0.0% | 0.00% | – |
Q4 2022 | $59 | -99.9% | 2,575 | 0.0% | 0.00% | – |
Q3 2022 | $59,000 | +63.9% | 2,575 | 0.0% | 0.00% | – |
Q2 2022 | $36,000 | -23.4% | 2,575 | +134.1% | 0.00% | – |
Q3 2021 | $47,000 | -52.0% | 1,100 | -50.0% | 0.00% | – |
Q2 2021 | $98,000 | +22.5% | 2,200 | 0.0% | 0.00% | – |
Q1 2021 | $80,000 | -83.4% | 2,200 | 0.0% | 0.00% | – |
Q4 2020 | $483,000 | +654.7% | 2,200 | 0.0% | 0.00% | – |
Q3 2020 | $64,000 | +77.8% | 2,200 | 0.0% | 0.00% | – |
Q2 2020 | $36,000 | +260.0% | 2,200 | +100.0% | 0.00% | – |
Q1 2020 | $10,000 | -44.4% | 1,100 | 0.0% | 0.00% | – |
Q4 2019 | $18,000 | -58.1% | 1,100 | -57.4% | 0.00% | – |
Q3 2019 | $43,000 | +115.0% | 2,580 | +134.5% | 0.00% | – |
Q2 2019 | $20,000 | 0.0% | 1,100 | 0.0% | 0.00% | – |
Q1 2019 | $20,000 | +53.8% | 1,100 | 0.0% | 0.00% | – |
Q4 2018 | $13,000 | – | 1,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 7,721,535 | $170,645,924 | 14.91% |
Gagnon Advisors, LLC | 360,758 | $7,972,751 | 5.34% |
Park West Asset Management LLC | 2,081,083 | $45,991,934 | 4.02% |
Meros Investment Management, LP | 324,479 | $7,170,986 | 3.56% |
GAGNON SECURITIES LLC | 637,576 | $14,090,429 | 2.93% |
Mesirow Financial Investment Management, Inc. | 16,947 | $374,529 | 1.59% |
Zweig-DiMenna Associates LLC | 256,000 | $5,657,600 | 0.71% |
GENEVA CAPITAL MANAGEMENT LLC | 1,561,443 | $34,507,882 | 0.68% |
PALISADE CAPITAL MANAGEMENT, LP | 1,134,352 | $25,069,179 | 0.67% |
Penbrook Management LLC | 41,500 | $917,150 | 0.66% |